Zhen‐Zhong Xu
- Physiology top 0.2%
- Pain Mechanisms and Treatments 35
- Cellular and Molecular Neuroscience top 0.5%
- Neuropeptides and Animal Physiology 19
- Neuroscience and Neuropharmacology Research 5
- Sensory Systems top 0.5%
- Ion Channels and Receptors 9
- Neurology top 1%
- Botulinum Toxin and Related Neurological Disorders 7
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology 4
-
- Fatty Acid Research and Health 5
-
- Reproductive Physiology in Livestock 4
Zhen‐Zhong Xu
56 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Physiology 3.8k
- Cellular and Molecular Neuroscience 2.2k
- Sensory Systems 578
- Neurology 730
- Biochemistry 547
Countries citing papers authored by Zhen‐Zhong Xu
This map shows the geographic impact of Zhen‐Zhong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen‐Zhong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen‐Zhong Xu more than expected).
Fields of papers citing papers by Zhen‐Zhong Xu
This network shows the impact of papers produced by Zhen‐Zhong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen‐Zhong Xu. The network helps show where Zhen‐Zhong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhen‐Zhong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 18 | |
| 2 | 2022 | 50 | |
| 3 | 2022 | 23 | |
| 4 | 2021 | 57 | |
| 5 | 2021 | 24 | |
| 6 | 2021 | 4 | |
| 7 | 2021 | 13 | |
| 8 | 2018 | 203 | |
| 9 | 2014 | 242 | |
| 10 | Emerging targets in neuroinflammation-driven chronic painbreakdown → | 2014 | 822 |
| 11 | 2013 | 62 | |
| 12 | 2012 | 100 | |
| 13 | 2012 | 16 | |
| 14 | 2011 | 211 | |
| 15 | 2011 | 196 | |
| 16 | Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actionsbreakdown → | 2010 | 480 |
| 17 | 2008 | 4 | |
| 18 | 2005 | 23 | |
| 19 | 2005 | 118 | |
| 20 | 1995 | 337 |
About Zhen‐Zhong Xu
Zhen‐Zhong Xu is a scholar working on Sensory Systems, Cellular and Molecular Neuroscience and Physiology, having authored 56 papers that have together received 7.5k indexed citations. Recurring topics across this work include Pain Mechanisms and Treatments (35 papers), Neuropeptides and Animal Physiology (19 papers), Ion Channels and Receptors (9 papers), Botulinum Toxin and Related Neurological Disorders (7 papers), Fatty Acid Research and Health (5 papers), Neuroscience and Neuropharmacology Research (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers) and Reproductive Physiology in Livestock (4 papers). The work is most often cited by research in Physiology (3.8k citations), Cellular and Molecular Neuroscience (2.2k citations) and Sensory Systems (578 citations). Zhen‐Zhong Xu has collaborated with scholars based in United States, China and Taiwan. Frequent co-authors include Ru‐Rong Ji, Yong‐Jing Gao, Temugin Berta, Charles N. Serhan, Chul‐Kyu Park, Jong Yeon Park, Ling Zhang, Tong Liu, Ning Lü and Yasuhiko Kawasaki. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.